AG
XENT

Aperio Group’s Intersect ENT, Inc XENT Stock Holding History

Aperio Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,584
Closed -$208K – 2410
2020
Q1 		$208K Sell
17,584
-5,653
-24% -$125K ﹤0.01% 2086
2019
Q4 		$579K Buy
23,237
+2,219
+11% +$45K ﹤0.01% 1724
2019
Q3 		$358K Buy
21,018
+11,315
+117% +$206K ﹤0.01% 1937
2019
Q2 		$221K Sell
9,703
-365
-4% -$9.84K ﹤0.01% 2143
2019
Q1 		$323K Buy
10,068
+1,597
+19% +$49.4K ﹤0.01% 1968
2018
Q4 		$239K Buy
+8,471
New +$248K ﹤0.01% 2053
2018
Q3 		– Sell
-5,912
Closed -$222K – 2307
2018
Q2 		$222K Buy
5,912
+502
+9% +$19.7K ﹤0.01% 2132
2018
Q1 		$213K Buy
+5,410
New +$198K ﹤0.01% 2117

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aperio Group's XENT Position: Q2 2020 in Review

Aperio Group sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 17,584 shares — an estimated $208K sold.

Aperio Group first reported a position in XENT in Q1 2018 and held it in 8 quarters. The position peaked at $579K in Q4 2019. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

  • Aperio Group reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
  • Aperio Group sold 17,584 Intersect ENT, Inc shares in Q2 2020, an estimated $208K.
  • Aperio Group first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 8 quarters.
  • Aperio Group's Intersect ENT, Inc position peaked at $579K in Q4 2019.
  • 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on Aperio Group's 13F filing for Q2 2020, filed 13 Aug 2020.